Activation of dopamine D1 receptors enhances cholinergic transmission and social cognition: A parallel dialysis and behavioural study in rats

International Journal of Neuropsychopharmacology

Volumn 10, Issue 3, 2007, Pages 383-399

  Di Cara, Benjamin ^a   Panayi, Fany ^a   Gobert, Alain ^a   Dekeyne, Anne ^a   Sicard, Dorothée ^a   De Groote, Lotte ^a   Millan, Mark J ^a  

^a INSTITUT DE RECHERCHES SERVIER   (France)

Author keywords

Acetylcholine; Cognition; Dopamine; Frontal cortex; Microdialysis

Indexed keywords

3 ALLYL 6 CHLORO 2,3,4,5 TETRAHYDRO 7,8 DIHYDROXY 1 PHENYL 1H 3 BENZAZEPINE; 6 CHLORO 2,3,4,5 TETRAHYDRO 7,8 DIHYDROXY 1 PHENYL 1H 3 BENZAZEPINE; 8 CHLORO 2,3,4,5 TETRAHYDRO 3 METHYL 5 PHENYL 1H 3 BENZAZEPIN 7 OL HYDROGEN MALEATE; ACETYLCHOLINE; ACETYLCHOLINESTERASE; DOPAMINE 1 RECEPTOR; GALANTAMINE; SCOPOLAMINE; BENZAZEPINE DERIVATIVE; CHOLINESTERASE INHIBITOR; DOPAMINE RECEPTOR BLOCKING AGENT; MUSCARINIC RECEPTOR; MUSCARINIC RECEPTOR BLOCKING AGENT; SK&F 81297; SK&F 82958; UNCLASSIFIED DRUG;

ACETYLCHOLINE BRAIN LEVEL; ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ARTICLE; CHOLINERGIC TRANSMISSION; COGNITION; CONTROLLED STUDY; DOPAMINERGIC ACTIVITY; DOPAMINERGIC SYSTEM; DOSE RESPONSE; DRUG POTENCY; DRUG RECEPTOR BINDING; FACILITATION; FRONTAL CORTEX; HIPPOCAMPUS; MALE; MICRODIALYSIS; NEUROMODULATION; NONHUMAN; PRIORITY JOURNAL; RAT; RECEPTOR AFFINITY; RECEPTOR OCCUPANCY; RECEPTOR SENSITIVITY; RECOGNITION; ANIMAL; CHOLINERGIC SYSTEM; DRUG ANTAGONISM; DRUG EFFECT; DRUG POTENTIATION; EXTRACELLULAR SPACE; METABOLISM; PHYSIOLOGY; PREFRONTAL CORTEX; SOCIAL BEHAVIOR; SYNAPTIC TRANSMISSION; WISTAR RAT;

ACETYLCHOLINE; ANIMALS; BEHAVIOR, ANIMAL; BENZAZEPINES; CHOLINESTERASE INHIBITORS; DOPAMINE ANTAGONISTS; EXTRACELLULAR SPACE; GALANTAMINE; HIPPOCAMPUS; MALE; MICRODIALYSIS; MUSCARINIC ANTAGONISTS; PARASYMPATHETIC NERVOUS SYSTEM; PREFRONTAL CORTEX; RATS; RATS, WISTAR; RECEPTORS, DOPAMINE D1; RECEPTORS, MUSCARINIC; RECOGNITION (PSYCHOLOGY); SCOPOLAMINE; SOCIAL BEHAVIOR; SYNAPTIC TRANSMISSION;

EID: 34247849235     PISSN: 14611457     EISSN: 14695111     Source Type: Journal    
DOI: 10.1017/S1461145706007103     Document Type: Article

References (89)

1. 1 receptor agonist A-77636 increases cortical and hippocampal acetylcholine release in the rat. European Journal of Pharmacology 260, 85-87.
2. Ammassari-Teule M, Amoroso D, Forloni GL, Rossi-Arnaud C, Consolo S (1993). Mechanical deafferentation of basal forebrain-cortical pathways and neurotoxic lesions of the nucleus basalis magnocellularis: comparative effect on spatial learning and cortical acetylcholine release in vivo. Behavioral Brain Research 54, 145-152.
3. Anglade F, Chapouthier G, Dodd RH, Baudoin C (1999). Olfactory memory in rats, cholinergic agents and benzodiazepine receptor ligands. Journal of Physiology (Paris) 93, 225-232.
4. 1 receptor mechanisms in the cognitive performance of young adult and aged monkeys. Psychopharmacology (Berlin) 116, 143-151.
5. 2 receptor affinity and efficacy determine whether dopamine agonists induce hyperactivity or oral stereotypy in rats. Pharmacology and Toxicology 62, 121-130.
6. Bach ME, Barad M, Son H, Zhuo M, Lu YF, Shih R, Mansuy I, Hawkins RD, Kandel ER (1999). Age-related defects in spatial memory are correlated with defects in the late phase of hippocampal long-term potentiation in vitro and are attenuated by drugs that enhance the cAMP signaling pathway. Proceedings of the National Academy of Sciences USA 96, 5280-5285.
7. 1A and cholinergic muscarinic receptors in cortical structures of the rat. Behavioral Brain Research 124, 1-7.
8. Bentley P, Husain M, Dolan RJ (2004). Effects of cholinergic enhancement on visual stimulation, spatial attention, and spatial working memory. Neuron 41, 969-982.
9. 5 dopamine receptors in primate brain. Journal of Neuroscience 15, 7821-7836.
10. Bielsky IF, Young LJ (2004). Oxytocin, vasopressin, and social recognition in mammals. Peptides 25, 1565-1574.
11. Bigl V, Woolf NJ, Butcher LL (1982). Cholinergic projections from the basal forebrain to frontal, parietal, temporal, occipital, and cingulate cortices: a combined fluorescent tracer and acetylcholinesterase analysis. Brain Research Bulletin 8, 727-749.
12. Bores GM, Huger FP, Petko W, Mutlib AE, Camacho F, Rush DK, Selk DE, Wolf V, Kosley Jr. RW, Davis L, Vargas HM (1996). Pharmacological evaluation of novel Alzheimer's disease therapeutics: acetylcholinesterase inhibitors related to galanthamine. Journal of Pharmacology and Experimental Therapeutics 277, 728-738.
13. Brunig I, Sommer M, Hatt H, Bormann J (1999). Dopamine receptor subtypes modulate olfactory bulb gamma-aminobutyric acid type A receptors. Proceedings of the National Academy of Sciences USA 96, 2456-2460.
14. 1 receptor agonists A77636 or SKF81297 on spatial working memory in aged monkeys. Journal of Pharmacology and Experimental Therapeutics 283, 183-189.
15. 1-like agonists, SKF 81297, SKF 82958 and A-77636, with cocaine: locomotor activity and drug discrimination studies in rodents. Psychopharmacology (Berlin) 159, 145-153.
16. (5) receptor immunolocalization in rat and monkey brain. Synapse 37, 125-145.
17. Coronas V, Krantic S, Jourdan F, Moyse E (1999). Dopamine receptor coupling to adenylyl cyclase in rat olfactory pathway: a combined pharmacological-radioautographic approach. Neuroscience 90, 69-78.
18. 1 receptors using an antibody capture assay: antagonist properties of clozapine. European Journal of Pharmacology 485, 111-117.
19. Dantzer R, Bluthe RM, Koob GF, Le Moal M (1987). Modulation of social memory in male rats by neurohypophyseal peptides. Psychopharmacology (Berlin) 91, 363-368.
20. Davis RL (2004). Olfactory learning. Neuron 44, 31-48.
21. Day J, Fibiger HC (1992). Dopaminergic regulation of cortical acetylcholine release. Synapse 12, 281-286.
22. Day J, Fibiger HC (1993). Dopaminergic regulation of cortical acetylcholine release: effects of dopamine receptor agonists. Neuroscience 54, 643-648.
23. Day JC, Fibiger HC (1994). Dopaminergic regulation of septohippocampal cholinergic neurons. Journal of Neurochemistry 63, 2086-2092.
24. Desimone R (1995). Neuropsychology. Is dopamine a missing link? Nature 376, 549-550.
25. Doty RL, Bagla R, Misra R, Mueller E, Kerr KL (2003). No influence of scopolamine hydrobromide on odor detection performance of rats. Chemical Senses 28, 761-765.
26. Doty RL, Li C, Bagla R, Huang W, Pfeiffer C, Brosvic GM, Risser JM (1998). SKF 38393 enhances odor detection performance. Psychopharmacology (Berlin) 136, 75-82.
27. Dubois B, Pilon B, Lhermitte F, Agid Y (1990). Cholinergic deficiency and frontal dysfunction in Parkinson's disease. Annals of Neurology 28, 117-121.
28. 2 dopamine receptors. Neuroscience 19, 125-137.
29. (1) receptor knockout mice. European Journal of Pharmacology 383, 95-106.
30. Everitt BJ, Robbins TW (1997). Central cholinergic systems and cognition. Annual Review of Psychology 48, 649-684.
31. Friedman JI (2004). Cholinergic targets for cognitive enhancement in schizophrenia: focus on cholinesterase inhibitors and muscarinic agonists. Psychopharmacology (Berlin) 174, 45-53.
32. Fujii T, Yoshizawa M, Nakai K, Fujimoto K, Suzuki T, Kawashima K (1997). Demonstration of the facilitatory role of 8-OH-DPAT on cholinergic transmission in the rat hippocampus using in vivo microdialysis. Brain Research 761, 244-249.
33. 2A-adrenoceptors: a dialysis comparison to talipexole and quinelorane in the absence of acetylcholinesterase inhibitors. Journal of Pharmacology and Experimental Therapeutics 305, 338-346.
34. 2 receptors enhances frontocortical cholinergic transmission and social memory in rats: a parallel neurochemical and behavioural analysis. Journal of Neurochemistry.
35. 1 receptor in the cognitive symptoms of schizophrenia. Neuropsychopharmacology 21, S170-S181.
36. 1 dopaminergic receptor agents into rat prefrontal cortex. Journal of Neurosciennce 20, 1208-1215.
37. 2-like compounds on cocaine self-administration in Lewis and Fischer 344 inbred rats. Journal of Pharmacology and Experimental Therapeutics 299, 509-518.
38. 5 receptor modulates hippocampal acetylcholine release. Brain Research. Molecular Brain Research 76, 336-340.
39. 1 receptors: a combined receptor autoradiography and in vivo dialysis study. Journal of Neuroscience 15, 7150-7157.
40. 1 receptor ligands modulate cognitive performance and hippocampal acetylcholine release in memory-impaired aged rats. Neuroscience 69, 1067-1074.
41. 5 receptor null mutant mice. Behavioral Neuroscience 115, 1129-1144.
42. (1) receptor in rats. Neurobiology of Learning and Memory 84, 85-92.
43. Hsia AY, Vincent JD, Lledo PM (1999). Dopamine depresses synaptic inputs into the olfactory bulb. Journal of Neurophysiology 82, 1082-1085.
44. 1 dopamine receptor in rat brain reveals its axonal transport, pre- and postsynaptic localization, and prevalence in the basal ganglia, limbic system, and thalamic reticular nucleus. Proceedings of the National Academy of Sciences USA 89, 11988-11992.
45. Ichikawa J, Dai J, Meltzer HY (2000). Acetylcholinesterase inhibitors are neither necessary nor desirable for microdialysis studies of brain acetylcholine. Current Separations 19, 37-44.
46. Ichikawa J, Dai J, O'Laughlin IA, Fowler WL, Meltzer HY (2002). Atypical, but not typical, antipsychotic drugs increase cortical acetylcholine release without an effect in the nucleus accumbens or striatum. Neuropsychopharmacology 26, 325-339.
47. 2 receptors facilitates in vivo acetylcholine release in the hippocampus. Brain Research 618, 341-345.
48. Insel TR, Fernald RD (2004). How the brain processes social information: searching for the social brain. Annual Review of Neuroscience 27, 697-722.
49. 3 receptor antagonists as therapeutic agents. Drug Discovery Today 10, 917-925.
50. 2 receptors in the rat hippocampal region. Neuroscience Letters 126, 107-109.
51. Laplante F, Sibley DR, Quirion R (2004). Reduction in acetylcholine release in the hippocampus of dopamine D5 receptor-deficient mice. Neuropsychopharmacology 29, 1620-1627.
52. 3 receptor antagonists improve the learning performance in memory-impaired rats. Psychopharmacology (Berlin) 179, 567-575.
53. Lawrence AD, Sahakian BJ (1998). The cognitive psychopharmacology of Alzheimer's disease: focus on cholinergic systems. Neurochemistry Research 23, 787-794.
54. Lee KH, Farrow TF, Spence SA, Woodruff PW (2004). Social cognition, brain networks and schizophrenia. Psychological Medicine 34, 391-400.
55. Levin ED, McGurk SR, Rose JE, Butcher LL (1990). Cholinergic-dopaminergic interactions in cognitive performance. Behavioral and Neural Biology 54, 271-299.
56. Li S, Cullen WK, Anwyl R, Rowan MJ (2003). Dopamine-dependent facilitation of LTP induction in hippocampal CA1 by exposure to spatial novelty. Nature Neuroscience 6, 526-531.
57. Liu JK, Kato T (1994). Effect of physostigmine on relative acetylcholine output induced by systemic treatment with scopolamine in in vivo microdialysis of rat frontal cortex. Neurochemistry International 24, 589-596.
58. Mesulam MM, Mufson EJ, Wainer BH, Levey AI (1983). Central cholinergic pathways in the rat: an overview based on an alternative nomenclature (Ch1-Ch6). Neuroscience 10, 1185-1201.
59. 1A receptor partial agonist S15535 [4-(benzodioxan-5-yl)1-(indan-2-yl)piperazine] enhances cholinergic transmission and cognitive function in rodents: a combined neurochemical and behavioral analysis. Journal of Pharmacology and Experimental Therapeutics 311, 190-203.
60. 2C receptors. Psychopharmacology (Berlin) 156, 58-62.
61. Mizoguchi K, Ishige A, Takeda S, Aburada M, Tabira T (2004). Endogenous glucocorticoids are essential for maintaining prefrontal cortical cognitive function. Journal of Neuroscience 24, 5492-5499.
62. Mizoguchi K, Yuzurihara M, Ishige A, Sasaki H, Chui DH, Tabira T (2000). Chronic stress induces impairment of spatial working memory because of prefrontal dopaminergic dysfunction. Journal of Neuroscience 20, 1568-1574.
63. Murphy BL, Arnsten AF, Jentsch JD, Roth RH (1996). Dopamine and spatial working memory in rats and monkeys: pharmacological reversal of stress-induced impairment. Journal of Neuroscience 16, 7768-7775.
64. Myhrer T (2003). Neurotransmitter systems involved in learning and memory in the rat: a meta-analysis based on studies of four behavioral tasks. Brain Research. Brain Research Review 41, 268-287.
65. Nieoullon A (2002). Dopamine and the regulation of cognition and attention. Progress in Neurobiology 67, 53-83.
66. 1 dopamine receptor. Neuropharmacology 28, 401-405.
67. Paxinos G, Watson S (1994). The Rat Brain in Stereotoxic Coordinates. Sydney: Academic Press.
68. Perio A, Terranova JP, Worms P, Bluthe RM, Dantzer R, Biziere K (1989). Specific modulation of social memory in rats by cholinomimetic and nootropic drugs, by benzodiazepine inverse agonists, but not by psychostimulants. Psychopharmacology (Berlin) 97, 262-268.
69. Prediger RD, Batista LC, Miyoshi E, Takahashi RN (2004). Facilitation of short-term social memory by ethanol in rats is mediated by dopaminergic receptors. Behavioral Brain Research 153, 149-157.
70. 2 receptor knock-out mice. Journal of Neuroscience 22, 9604-9611.
71. Rodrigo J, Fernandez P, Bentura ML, de Velasco JM, Serrano J, Uttenthal O, Martinez-Murillo R (1998). Distribution of catecholaminergic afferent fibres in the rat globus pallidus and their relations with cholinergic neurons. Journal of Chemical Neuroanatomy 15, 1-20.
72. Runyan JD, Dash PK (2004). Intra-medial prefrontal administration of SCH-23390 attenuates ERK phosphorylation and long-term memory for trace fear conditioning in rats. Neurobiology of Learning and Memory 82, 65-70.
73. Sarter M, Bruno JP (1997). Cognitive functions of cortical acetylcholine: toward a unifying hypothesis. Brain Research. Brain Research Review 23, 28-46.
74. 1 dopamine receptors in prefrontal cortex: involvement in working memory. Science 251, 947-950.
75. 1 receptor modulation of hippocampal-prefrontal cortical circuits integrating spatial memory with executive functions in the rat. Journal of Neuroscience 18, 1613-1621.
76. Shirazi-Southall S, Rodriguez DE, Nomikos GG (2002). Effects of typical and atypical antipsychotics and receptor selective compounds on acetylcholine efflux in the hippocampus of the rat. Neuropsychopharmacology 26, 583-594.
77. 1A dopamine receptors. Neuroscience 86, 135-146.
78. Soffié M, Lamberty Y (1988). Scopolamine effects on juvenile conspecific recognition in rats: possible interactions with olfactory sensitivity. Behavioral Processes 17, 181-199.
79. 1 agonist dihydrexidine releases acetylcholine and improves cognitive performance in rats. Pharmacology Biochemistry and Behavior 58, 477-483.
80. 1 cannabinoid receptor antagonist, SR 141716. Psychopharmacology (Berlin) 126, 165-172.
81. Tiberi M, Caron MG (1994). High agonist-independent activity is a distinguishing feature of the dopamine D1B receptor subtype. Journal of Biological Chemistry 269, 27925-27931.
82. Wilkinson DG, Francis PT, Schwam E, Payne-Parrish J (2004). Cholinesterase inhibitors used in the treatment of Alzheimer's disease: the relationship between pharmacological effects and clinical efficacy. Drugs Aging 21, 453-478.
83. Winslow JT, Camacho F (1995). Cholinergic modulation of a decrement in social investigation following repeated contacts between mice. Psychopharmacology (Berlin) 121, 164-172.
84. Winters B, Matheson WR, McGregor IS, Brown RE (2000). An automated two-choice test of olfactory working memory in the rat: Effect of scopolamine. Psychobiology 28, 21-31.
85. 2+. Hippocampus 10, 57-63.
86. 2 receptor activation on odor discrimination learning. Behavioral Neuroscience 118, 184-190.
87. Zaborszky L, Cullinan WE (1996). Direct catecholaminergic- cholinergic interactions in the basal forebrain. I. Dopamine-beta-hydroxylase- and tyrosine hydroxylase input to cholinergic neurons. Journal of Comparative Neurology 374, 535-554.
88. 1 dopamine receptors in the rodent prefrontal cortex impairs spatial working memory performance. Journal of Neuroscience 17, 8528-8535.
89. Zmarowski A, Sarter M, Bruno JP (2005). NMDA and dopamine interactions in the nucleus accumbens modulate cortical acetylcholine release. European Journal of Neuroscience 22, 1731-1740.